Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.015 SEK | +1.91% | -0.98% | -41.50% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Öhd
CEO | Chief Executive Officer | 53 | 17-12-31 |
Claes Lindblad
DFI | Director of Finance/CFO | 57 | 21-03-14 |
Ellen Donnelly
BRD | Director/Board Member | 50 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Viktor Drvota
CHM | Chairman | 59 | 15-12-31 |
Director/Board Member | 65 | 13-12-31 | |
Ellen Donnelly
BRD | Director/Board Member | 50 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 35,938,899 | 3,774,998 ( 10.50 %) | 0 | 10.50 % |
Company contact information
Modus Therapeutics Holding AB
Olof Palmes gata 29 IV
111 22, Stockholm
+46 8 50 13 70 00
http://www.modustx.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.50% | 3.28M | |
+2.03% | 42.59B | |
+7.48% | 40.65B | |
+49.11% | 40.57B | |
-11.96% | 26.77B | |
+8.34% | 24.81B | |
-23.92% | 18.17B | |
+27.40% | 12.05B | |
-2.77% | 11.7B | |
+7.02% | 11.1B |
- Stock Market
- Equities
- MODTX Stock
- Company Modus Therapeutics Holding AB